前列腺癌:在临床前的In Vivo模型中有效的无调节的循环RNA
Ulrich H Weidle1, Fabian Birzele2
1Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de fabian.birzele@roche.com.
Cancer genomics & proteomics
|February 24, 2025
概括
循环RNAs (circRNAs) 是前列腺癌进展和治疗耐药性的关键调节者. 识别失调的circRNAs为改善前列腺癌治疗疗效提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 前列腺癌的治疗面临着重大挑战,原因是治疗耐药性,包括割耐药性和转移.
- 循环RNAs (circRNAs) 越来越多地被认为对癌症的发展和进展起着作用.
研究的目的:
- 在临床前前列腺癌模型中识别影响治疗疗效的失调circRNAs.
- 发现新的治疗点和克服前列腺癌耐药性的战略.
主要方法:
- 在PubMed.com上进行了全面的文献搜索.
- 专注于与治疗耐药性相关的前列腺癌的临床前 * in vivo * 模型.
- 识别和目录放松调节的circRNA及其相关的生物过程.
主要成果:
- 确定了49个涉及各种癌症相关过程的circRNAs.
- 这些circRNA与治疗耐药性,蛋白调节,信号通路和表观遗传修饰有关.
- 特定的circRNA与跨膜和分泌蛋白质,转录因子和新陈代谢有关.
结论:
- 失调的circRNAs代表前列腺癌治疗的有希望的目标.
- 下调的circRNAs可能是复制疗法的候选者.
- 上调的circRNAs可能会被小干扰RNA (siRNA),反意义寡核酸 (ASO) 或CRISPR-Cas方法所准.
相关概念视频
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
01:22MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K